OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status
Shigeharu Fujieda, Shoji Matsune, Sachio Takeno, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 186-196
Open Access | Times Cited: 74
Shigeharu Fujieda, Shoji Matsune, Sachio Takeno, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 186-196
Open Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 159
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 159
The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps
Philippe Gevaert, Joseph K. Han, Steven G. Smith, et al.
International Forum of Allergy & Rhinology (2022) Vol. 12, Iss. 11, pp. 1413-1423
Open Access | Times Cited: 77
Philippe Gevaert, Joseph K. Han, Steven G. Smith, et al.
International Forum of Allergy & Rhinology (2022) Vol. 12, Iss. 11, pp. 1413-1423
Open Access | Times Cited: 77
Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps
Junqin Bai, Julia Huang, Caroline P.E. Price, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 2, pp. 352-361.e7
Open Access | Times Cited: 73
Junqin Bai, Julia Huang, Caroline P.E. Price, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 2, pp. 352-361.e7
Open Access | Times Cited: 73
Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis
Shiru Cai, Shenglong Xu, Hongfei Lou, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 7, pp. 1876-1886.e7
Closed Access | Times Cited: 60
Shiru Cai, Shenglong Xu, Hongfei Lou, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 7, pp. 1876-1886.e7
Closed Access | Times Cited: 60
Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease
Kathleen M. Buchheit, Aaqib Sohail, Jonathan Hacker, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 2, pp. 415-424
Open Access | Times Cited: 57
Kathleen M. Buchheit, Aaqib Sohail, Jonathan Hacker, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 2, pp. 415-424
Open Access | Times Cited: 57
Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia
F Fujieda, Chenwei Wang, Mamoru Yoshikawa, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 10
F Fujieda, Chenwei Wang, Mamoru Yoshikawa, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 10
Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID ‐exacerbated respiratory disease
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3593-3605
Closed Access | Times Cited: 29
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3593-3605
Closed Access | Times Cited: 29
Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial
Yuan Zhang, Bing Yan, Shen Shen, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102076-102076
Open Access | Times Cited: 22
Yuan Zhang, Bing Yan, Shen Shen, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102076-102076
Open Access | Times Cited: 22
Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents’ efficacy
George Papacharalampous, Jannis Constantinidis, G. Fotiadis, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 1, pp. 96-109
Open Access | Times Cited: 21
George Papacharalampous, Jannis Constantinidis, G. Fotiadis, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 1, pp. 96-109
Open Access | Times Cited: 21
Dupilumab‐induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis
Fabio S. Ryser, Ayla Yalamanoglu, Alan Valaperti, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2712-2723
Open Access | Times Cited: 18
Fabio S. Ryser, Ayla Yalamanoglu, Alan Valaperti, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2712-2723
Open Access | Times Cited: 18
Eosinophils—from cradle to grave
Miloš Jeseňák, Zuzana Diamant, Dagmar Simon, et al.
Allergy (2023) Vol. 78, Iss. 12, pp. 3077-3102
Open Access | Times Cited: 18
Miloš Jeseňák, Zuzana Diamant, Dagmar Simon, et al.
Allergy (2023) Vol. 78, Iss. 12, pp. 3077-3102
Open Access | Times Cited: 18
The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics
A. Wautlet, Claus Bachert, Martin Desrosiers, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2642-2651
Closed Access | Times Cited: 17
A. Wautlet, Claus Bachert, Martin Desrosiers, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2642-2651
Closed Access | Times Cited: 17
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
The role of hypoxia in the pathophysiology of chronic rhinosinusitis
Bing Zhong, Jun Jie Seah, Feng Liu, et al.
Allergy (2022) Vol. 77, Iss. 11, pp. 3217-3232
Closed Access | Times Cited: 20
Bing Zhong, Jun Jie Seah, Feng Liu, et al.
Allergy (2022) Vol. 77, Iss. 11, pp. 3217-3232
Closed Access | Times Cited: 20
Radiological Versus Clinical 1‐Year Outcomes of Dupilumab in Refractory CRSwNP : A Real‐Life Study
Francesco Giombi, Gian Marco Pace, Emanuele Nappi, et al.
The Laryngoscope (2023) Vol. 134, Iss. 6, pp. 2626-2633
Closed Access | Times Cited: 11
Francesco Giombi, Gian Marco Pace, Emanuele Nappi, et al.
The Laryngoscope (2023) Vol. 134, Iss. 6, pp. 2626-2633
Closed Access | Times Cited: 11
The value of biomarkers in the therapy of CRSwNP with biologicals—a long-term follow-up of dupilumab therapy
Sven Ole Sarnoch, Amra Pepić, Lisa Schmitz, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4789-4805
Open Access | Times Cited: 4
Sven Ole Sarnoch, Amra Pepić, Lisa Schmitz, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4789-4805
Open Access | Times Cited: 4
Outcome measures for chronic rhinosinusitis with nasal polyps
Ahmad R. Sedaghat, Raewyn G. Campbell, Richard Douglas, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 4
Ahmad R. Sedaghat, Raewyn G. Campbell, Richard Douglas, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 4
Personalized Medicine in Chronic Rhinosinusitis: Treatable Traits Using Biologics for Unmet Needs
Mitsuhiro Okano, Marie Yamada, Aiko Oka
Allergy Asthma and Immunology Research (2025) Vol. 17, Iss. 1, pp. 8-8
Open Access
Mitsuhiro Okano, Marie Yamada, Aiko Oka
Allergy Asthma and Immunology Research (2025) Vol. 17, Iss. 1, pp. 8-8
Open Access
Dupilumab in the Treatment of Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma—A Multidisciplinary Monocentric Real-Life Study
Gian Luca Fadda, Cecilia Rustichelli, Simone Soccal, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 501-501
Open Access
Gian Luca Fadda, Cecilia Rustichelli, Simone Soccal, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 501-501
Open Access
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: A systematic review and meta-analysis
Linger Sim, Norasnieda Md Shukri, Najib Majdi Yaacob, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Linger Sim, Norasnieda Md Shukri, Najib Majdi Yaacob, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
The Points at Issue in Pathophysiology and Clinical Approach of Rhinosinusitis
Shoji Matsune
Practica oto-rhino-laryngologica Suppl (2025) Vol. 167, pp. 1-41
Closed Access
Shoji Matsune
Practica oto-rhino-laryngologica Suppl (2025) Vol. 167, pp. 1-41
Closed Access
Differential Immune Cell Infiltration in Eosinophilic and Non‐Eosinophilic CRS: Correlations With Clinical, Endoscopic, and Radiological Findings
Katarzyna Czerwaty, Katarzyna Piszczatowska, Mirosław J. Szczepański, et al.
International Forum of Allergy & Rhinology (2025)
Open Access
Katarzyna Czerwaty, Katarzyna Piszczatowska, Mirosław J. Szczepański, et al.
International Forum of Allergy & Rhinology (2025)
Open Access
Endotyping Chronic Rhinosinusitis with Nasal Polyps: Understanding Inflammation Beyond Phenotypes
Chongjia C. Chen, Kathleen M. Buchheit
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 2, pp. 132-139
Closed Access | Times Cited: 10
Chongjia C. Chen, Kathleen M. Buchheit
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 2, pp. 132-139
Closed Access | Times Cited: 10
Biological Treatment for Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: Preliminary Real-World Results from a Tertiary Medical Center
Reut Book, Shalom Eligal, Yuval Tal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3671-3671
Open Access | Times Cited: 10
Reut Book, Shalom Eligal, Yuval Tal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3671-3671
Open Access | Times Cited: 10
